Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Amalgamated Bank

Amalgamated Bank lowered its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 2.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 122,401 shares of the real estate investment trust’s stock after selling 2,623 shares during the quarter. Amalgamated Bank’s holdings in Omega Healthcare Investors were worth $4,982,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. grew its position in Omega Healthcare Investors by 0.5% in the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock valued at $1,120,478,000 after acquiring an additional 165,105 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after purchasing an additional 272,299 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Omega Healthcare Investors by 4.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock worth $110,971,000 after buying an additional 143,521 shares during the period. LSV Asset Management lifted its holdings in Omega Healthcare Investors by 0.7% in the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock worth $67,411,000 after buying an additional 14,000 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its position in Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock valued at $32,384,000 after buying an additional 861,907 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. BMO Capital Markets increased their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Scotiabank lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Finally, Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and a consensus price target of $39.70.

Omega Healthcare Investors Stock Up 2.9 %

Shares of NYSE:OHI opened at $40.75 on Friday. The company’s fifty day moving average is $40.55 and its two-hundred day moving average is $36.24. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The stock has a market capitalization of $11.00 billion, a price-to-earnings ratio of 29.96, a price-to-earnings-growth ratio of 1.29 and a beta of 0.99.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.58%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.